Skip Navigation

PolicyBot

Search our database by keyword or with the filters below.

Search Results

217 items
Sort  Date (recent first)  |  Relevancy
View  10  |  20  |  40
December 1, 2004
By Malcolm Gladwell
Ten years ago, the multinational pharmaceutical company AstraZeneca launched what was known inside the company as the Shark Fin Project.
Tags
Health Care
September 1, 2004
By Devon Herrick and Russell Bennett
In July, the U.S. House and Senate passed and sent to the president the U.S.-Australia Free Trade Agreement.
Tags
Health Care
April 13, 2020
By Ashley Bateman
The so-call "Purple Book" is a list of all licensed biologic products and is a reference guide for patients, providers, payers and manufactureres.
Tags
Health Care
Regulation
April 2, 2020
By David Gortler
America is completely dependent on China and India for its pharmaceutical drug supply.
Tags
Health Care
December 17, 2019
By Bonner R. Cohen
The U.S. Senate considers the nomination of Stephen Hahn to head the FDA.
Tags
Health Care
Regulation
December 5, 2019
Parmacogenetic testing is a new field in prescription medicine.
Tags
Health Care
Regulation
May 28, 2019
By AnneMarie Schieber
The biosimilar drug industry, along with consumer, taxpayer and health care groups are crying foul over the Food and Drug Administration’s newly released guidelines requiring a four-letter suffix on biosimilar drug names that would distinguish them from t
Tags
Health Care
Regulation
November 20, 2018
By Christopher Talgo
The U.S. Food and Drug Administration (FDA) approved a record number of generic drugs in fiscal year 2018.
Tags
Health Care
May 2, 2019
Seven groups express concern over FDA's newly released guidelines onbio similar naming
Tags
Health Care
Health Care
July 26, 2017
By
The federal agency has published the list to enhance competition.
Tags
Health Care
Regulation
 

Over 32,000 documents and resources at your fingertips

PolicyBot is a free online database and search engine operated by The Heartland Institute. It is the fastest and easiest way to find the best work of the nation's leading free-market think tanks and advocacy groups. It's the perfect research tool for students, legislative staff, editors, and activists.

Latest Uploads